The European Myelodysplastic Syndromes Cooperative Group (EMSCO) serves as a platform to foster academic clinical research, education and consulting in the field of myelodysplastic syndromes (MDS).

EMSCO is administered by GWT-TUD GmbH and was founded in 2013 upon an initiative of the European Leukemia Network (ELN). Originally founded to facilitate European MDS-specific trials, EMSCO soon also became active in organizing indication specific conferences and in serving as contact point for clinical research consulting.